High-Deductible Health Plans Linked to Delayed Diagnosis of Metastatic Cancer
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
All articles by Alan P. Lyss, MD
Eponyms in Oncology: Peutz-Jeghers Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Peutz-Jeghers syndrome.
Eponyms in Oncology: Von Hippel-Lindau Disease
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of von Hippel-Lindau disease.
Eponyms in Oncology: Bence-Jones Protein
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Bence-Jones protein.
Long-Term Benefit Observed With Sotorasib in KRAS-Mutant Non-Small Cell Lung Cancer
The 2-year overall survival rate was 32.5%.
Eponyms in Oncology: Zollinger-Ellison Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Zollinger-Ellison syndrome.
Recurrent DCIS Not Always Related to Primary Tumor
Researchers found that, in 18% of recurrences, the new tumor was molecularly unrelated to the original tumor.
Eponyms in Oncology: Li-Fraumeni Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
Eponyms in Oncology: Lynch Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Lynch syndrome.
Eponyms in Oncology: HeLa Cells
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of HeLa cells.
- Loading...
Loading...
Next post in Eponyms in Oncology
Loading... 
Loading...